13-48090363-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014166.4(MED4):c.181G>A(p.Glu61Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000578 in 1,592,912 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00059 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00058 ( 1 hom. )
Consequence
MED4
NM_014166.4 missense
NM_014166.4 missense
Scores
3
5
11
Clinical Significance
Conservation
PhyloP100: 6.98
Genes affected
MED4 (HGNC:17903): (mediator complex subunit 4) This gene encodes a component of the Mediator complex. The Mediator complex interacts with DNA-binding gene-specific transcription factors to modulate transcription by RNA polymerase II. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.08944222).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MED4 | NM_014166.4 | c.181G>A | p.Glu61Lys | missense_variant | 2/7 | ENST00000258648.7 | NP_054885.1 | |
MED4 | NM_001270629.2 | c.43G>A | p.Glu15Lys | missense_variant | 2/7 | NP_001257558.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MED4 | ENST00000258648.7 | c.181G>A | p.Glu61Lys | missense_variant | 2/7 | 1 | NM_014166.4 | ENSP00000258648 | P1 | |
MED4 | ENST00000417167.2 | c.115G>A | p.Glu39Lys | missense_variant | 3/8 | 5 | ENSP00000413595 | |||
MED4 | ENST00000378586.5 | c.43G>A | p.Glu15Lys | missense_variant | 2/7 | 2 | ENSP00000367849 |
Frequencies
GnomAD3 genomes AF: 0.000587 AC: 89AN: 151738Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
89
AN:
151738
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000425 AC: 99AN: 233000Hom.: 1 AF XY: 0.000373 AC XY: 47AN XY: 125970
GnomAD3 exomes
AF:
AC:
99
AN:
233000
Hom.:
AF XY:
AC XY:
47
AN XY:
125970
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000577 AC: 831AN: 1441060Hom.: 1 Cov.: 29 AF XY: 0.000547 AC XY: 392AN XY: 716382
GnomAD4 exome
AF:
AC:
831
AN:
1441060
Hom.:
Cov.:
29
AF XY:
AC XY:
392
AN XY:
716382
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000586 AC: 89AN: 151852Hom.: 0 Cov.: 32 AF XY: 0.000673 AC XY: 50AN XY: 74270
GnomAD4 genome
AF:
AC:
89
AN:
151852
Hom.:
Cov.:
32
AF XY:
AC XY:
50
AN XY:
74270
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
9
ExAC
AF:
AC:
45
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.181G>A (p.E61K) alteration is located in exon 2 (coding exon 2) of the MED4 gene. This alteration results from a G to A substitution at nucleotide position 181, causing the glutamic acid (E) at amino acid position 61 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;D;T
Sift4G
Uncertain
D;T;.
Polyphen
P;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at